From ∗The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou
†Mental Health Prevention Hospital of Haidian District in Beijing, Beijing
‡Shenzhen Traditional Chinese Medicine Hospital, Shenzhen
§The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital & the Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing
∥Xiamen Xian Yue Hospital, Xiamen, China
¶University of Notre Dame Australia, Fremantle, Australia
#Division of Psychiatry, School of Medicine, University of Western Australia, Perth, Australia
∗∗West Region, Institute of Mental Health, Singapore
††Unit of Psychiatry, Institute of Translational Medicine, Faculty of Health Sciences, & Center for Cognition and Brain Sciences, University of Macau, Macao SAR, China.
Received January 18, 2020; accepted after revision April 30, 2020.
Reprints: Yu-Tao Xiang, MD, PhD, 3/F, Bldg E12, Faculty of Health Sciences, University of Macau, Avenida da Universidade, Taipa, Macau SAR, China (e-mail: [email protected]); or Yu-Ping Ning, MD, PhD, the Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China (e-mail: [email protected]).
The study was supported by the National Natural Science Foundation of China (81601169), the Major Science and Technology Award of the Science and Technology Department of Guangdong Province (2016B010108003), and the Science and Technology Plan Project of Guangdong Province (2019B030316001).
W.Z., Y.-Q.X., D.-B.C., and X.-H.Y. contributed equally to the article.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.psychopharmacology.com).
